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The strategy for the management of adult patients with congenital heart disease (CHD) 
often represents a challenge for cardiac surgeons and cardiologists due to complex 
anatomy, wide range of clinical presentations, and a high-risk profile. However, hybrid 
approach may represent an attractive solution. We report three cases of adult patients 
previously operated for CHD and recently treated with a hybrid approach in our 
institution. Case 1: a 76-year-old woman with permanent atrial fibrillation, lung disease, 
chronic kidney disease, microcytic anemia, and type II diabetes mellitus, previously 
operated for atrial septal defect closure and pulmonary valvotomy, presented with severe 
pulmonary regurgitation and advanced right ventricular failure. In order to minimize the 
surgical risk, a hybrid approach was used: an extensive right ventricular outflow tract 
(RVOT) plication was followed by implantation of an Edwards Sapien XT prosthesis in 
the RVOT through the right ventricular apex, without cardiopulmonary bypass. Case 2: 
a 64-year-old man with previous atrial septum excision and pericardial baffle for partial 
anomalous pulmonary venous drainage with intact interatrial septum, presented with 
worsening dyspnea, right ventricular failure, and pulmonary hypertension caused by 
baffle stenosis. His comorbidities included coronary artery disease, atrial flutter, and 
previous left pneumonectomy. After performing a redo longitudinal median sternotomy, 
a 20-mm stent was implanted in the baffle with access through the superior vena cava. 
Case 3: a 50-year-old man, with previous atrioventricular septal defect repair, followed 
by mitral valve replacement with a mechanical prosthesis, subsequently developed 
a paravalvular leak (PVL) with severe mitral regurgitation and severe left ventricular 
dysfunction. He underwent a transapical PVL device closure with two Amplatzer 
Vascular Plugs. In our opinion, hybrid surgery is a promising therapeutic modality that 
increases the available treatment options for this patient population. A multidisciplinary 
and patient-tailored approach is crucial in these complex clinical scenarios.
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FiguRe 1 | Baseline pulmonary regurgitation showed by intraoperative transesophageal echocardiography (a) and 29-mm edwards sapien Xt prosthesis 
within an andramed as43XXL stent implanted in the pulmonary position (B).
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iNtRoDuCtioN
The surgical and cardiological approach to patients with 
congenital heart disease (CHD) has been constantly evolving, 
and the life expectancy of this cohort of patients is increasing. 
Therefore, a significant number of adult patients with CHD, 
complex anatomy, and high-risk profile need multiple operations 
throughout their life. In this context, reoperations often carry 
a considerable morbidity and mortality risk that is determined 
both by technical issues and by the potentially detrimental effects 
of cardiopulmonary bypass (CPB) and cardioplegic arrest.
Hybrid procedures performed in dedicated theaters by a team 
of cardiac surgeons and cardiologists have been developed in 
order to minimize the surgical risk in specific patient popula-
tions (1), and they are currently widely adopted in several fields 
of both adult and pediatric cardiac surgery such as aortic arch 
disease, hypoplastic left heart syndrome, and ventricular septal 
defect closure (2, 3).
We have been increasingly performing hybrid procedures also 
in adult patients with CHD at Bristol Heart Institute. Here, we 
report three cases of patients who previously underwent cardiac 
operations for CHD and who have been successfully treated with 
a hybrid approach.
Case RepoRts
Case 1
A 76-year-old woman underwent a secundum atrial septal defect 
(ASD) closure and pulmonary valvotomy at the age of 32 at 
another institution. She presented with severe pulmonary regur-
gitation associated with clinical and echocardiographic signs of 
advanced right ventricular failure, including diffuse peripheral 
edema and a dilated right ventricle with septal flattening and 
moderate tricuspid regurgitation; the main pulmonary artery 
diameter was 47 mm. Her chest X-ray showed an enlarged heart 
and main pulmonary arteries. Cardiac catheterization and car-
diac magnetic resonance imaging demonstrated a dilated main 
pulmonary artery and branch pulmonary arteries.
This patient had a past medical history of diabetes mellitus, 
peripheral vascular disease associated with stage 3 chronic kidney 
disease (CKD), and bowel angiodysplasia with symptomatic 
microcytic anemia. She also had undergone an unsuccessful 
catheter ablation for non-isthmus-dependent atrial flutter, and 
she was chronically anticoagulated with warfarin when presented 
to our team.
The estimated glomerular filtration rate on preoperative blood 
tests was 39 ml/min/1.73 m2.
In order to minimize the surgical risk and to avoid the poten-
tial complications of CPB in a patient with chronic bleeding, 
peripheral vascular disease, and CKD, it was decided to hybridly 
implant an Edwards Sapien XT prosthesis (Edwards Lifesciences, 
Irvine, CA, USA) in the right ventricular outflow tract (RVOT) 
within the native pulmonary valve.
A redo longitudinal median sternotomy and an extensive lon-
gitudinal plication of the main pulmonary artery and infundibu-
lar area were performed using a continuous 3-0 Prolene stitch 
reinforced with two Teflon strips. Transesophageal and epicardial 
echocardiogram, as well as angiography, were used to confirm 
that the RVOT had been adequately downsized prior to proceed-
ing with transcatheter pulmonary valve implantation (TPVI). A 
purse string suture was then placed on the anterior surface of the 
right ventricle. Through this perventricular access, an Andramed 
AndraStent AS43XXL stent (Andramed GmbH, Reutlingen, 
Germany) premounted on a 28 mm × 5 cm BIB balloon (PFM 
Medical, Koln, Germany) was implanted in the RVOT; the inner 
balloon was inflated to 4 Atm, the outer balloon was inflated to 
2 Atm. Finally, a 29-mm Edwards Sapien XT prosthesis was posi-
tioned within the stent (Figures 1A,B show baseline pulmonary 
regurgitation on transesophageal echocardiography and final 
result on fluoroscopy, respectively).
A routine transthoracic echocardiogram was performed 
5 days after the procedure, and it demonstrated moderate right 
ventricular impairment and low gradient across the pulmonary 
prosthesis (maximum velocity 1.8 m/s, mean gradient 7 mmHg, 
maximum gradient 13 mmHg) with no pulmonary regurgitation. 
The patient was discharged home 13 days postoperatively.
FiguRe 2 | gated computed tomography scan showing severe stenosis at the left atrial end of the pericardial baffle [(a), arrow] and 16 mm × 45 mm 
premounted Cp stent expanded within the pericardial baffle [(B), the sheath can be seen in the stump of the superior vena cava].
3
Rapetto et al. Hybrid Approaches to Complex ACHD
Frontiers in Surgery | www.frontiersin.org February 2017 | Volume 4 | Article 7
Case 2
A 64-year-old man underwent repair of partial right-sided 
anomalous pulmonary venous drainage (PAPVD) with intact 
interatrial septum. At this operation, the atrial septum was 
excised to create a pericardial baffle for the pulmonary veins 
to drain into the left atrium. The anomalous pulmonary veins 
entered the superior vena cava high above the level of the right 
pulmonary artery; therefore, the superior vena cava transection 
and relocation approach had been chosen to correct the defect. 
Over time, the atrial septum had grown back, therefore caus-
ing pulmonary venous stenosis. As a consequence, the patient 
presented with NYHA class III dyspnea, right ventricular failure, 
and pulmonary hypertension.
The preoperative echocardiogram showed a severely dilated 
right heart with a tricuspid annulus of 58 mm, severe pulmonary 
hypertension suggested by a tricuspid regurgitation jet velocity of 
4 m/s, and normal left ventricular function. A preoperative com-
puted tomography scan was performed, and it demonstrated a 
severely dilated right ventricle (end-diastolic diameter of 68 mm) 
and a severe stenosis at the distal end of the baffle (Figure 2A). 
Mild coronary artery disease was also present, and it was con-
firmed by the preoperative coronary angiogram.
The patient had several comorbidities, including type II 
diabetes mellitus and paroxysmal atrial fibrillation on Warfarin; 
furthermore, he had undergone a left pneumonectomy at the age 
of 4 due to rubella, and he had subsequently experienced recur-
rent low respiratory tract infections on his right lung.
Having considered the comorbidities and the high risk for 
complications on the right lung that a conventional open heart 
reoperation would have carried, it was decided to address the 
pericardial baffle stenosis through an interventional hybrid 
approach. In order to gain access to the pulmonary venous 
system, a redo longitudinal median sternotomy was performed, 
and after dissection of the adhesions a purse string suture was 
placed on the stump of the native superior vena cava. A 14 F 
sheath was then inserted and a 16 mm × 45 mm Premounted 
CP Stent (PFM Medical, Koln, Germany) was implanted within 
the pericardial baffle on the beating heart and avoiding CPB. 
The stent was then post-dilated with a 20-mm Cristal balloon 
(BALT Extrusion, Montmorency, France). Transesophageal 
echo and angiography were used to confirm the good result; no 
gradient across the stent was measured. The final result is shown 
in Figure 2B.
The early postoperative course was uneventful. The patient 
was electively readmitted to our institution 6  months after the 
procedure to have a cardiac catheterization as part of the workup 
for his pulmonary hypertension. This demonstrated pulmonary 
hypertension secondary to lung disease and confirmed the baffle 
stent to be patent, showing half-systemic pulmonary artery pres-
sure with a calculated pulmonary vascular resistance of 4 Wood 
Units, a pulmonary capillary wedge pressure of 13 mmHg, and 
a mean gradient across the stent (between pulmonary capillary 
wedge pressure and left ventricular end-diastolic pressure) of 
5 mmHg.
Case 3
A 50-year-old man previously undergoing primum ASD patch 
closure and left atrioventricular valve cleft repair at the age of 
6, developed left atrioventricular valve regurgitation, and the 
valve was replaced with a 29-mm mechanical prosthesis at the 
age of 20.
His past medical history also included permanent atrial 
fibrillation with complete heart block and need for permanent 
pacemaker at the age of 40. The patient then developed severe 
left ventricular dysfunction, and his pacemaker was upgraded to 
a biventricular defibrillator (CRT-D) at the age of 46.
He presented to our team with worsening dyspnea, cardiac fail-
ure, and anemia. A transthoracic echocardiogram showed severe 
left atrioventricular valve paravalvular regurgitation, moderate/
severe left ventricular dysfunction, severe tricuspid regurgitation, 
and moderate pulmonary hypertension; the mean gradient across 
the mechanical prosthesis was 6 mmHg. A left and right cardiac 
catheterization with coronary angiogram confirmed pulmonary 
hypertension and demonstrated normal coronary arteries.
FiguRe 3 | aVp3 14/5 devices shown in final position in short axis on fluoroscopy (a). Color Doppler showing baseline paravalvular leak (B) and final result 
after device closure (C) on intraoperative transoesophageal echocardiography.
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The preoperative blood tests suggested hemolysis to be the 
cause of the anemia, with increased lactate dehydrogenase (LDH) 
and reduced haptoglobin; hemoglobinuria was also found.
The transthoracic echo was assessed by our team, and it was 
decided to address the paravalvular leak (PVL) with a transapi-
cal trancatheter approach; this approach allowed avoidance of 
a third sternotomy, CPB, and cardioplegic cardiac arrest in a 
patient with significantly depressed left ventricular ejection 
fraction.
A left anterolateral minithoracotomy was performed, and the 
pericardium was opened in the apical region. Two purse string 
sutures were placed on the left ventricular apex. An 11 F sheath 
was inserted within the purse strings, and the PVL was crossed 
with a wire; two AVP3 14/5 mm Amplatzer Vascular Plug devices 
(St. Jude Medical Inc., St. Paul, MN, USA) were then implanted 
to close the leak (Figure  3A). Intraoperative transesophageal 
echocardiogram demonstrated a good final result with residual 
trivial paravalvular regurgitation (Figures  3B,C show baseline 
PVL and final result, respectively).
The patient was discharged home 7 days after the procedure. 
Laboratory findings still suggested some degree of hemolytic 
anemia, with increased indirect bilirubin, increased LDH, 
and reduced haptoglobin. Nevertheless, in respect to his heart 
failure, there had been symptomatic improvement at follow-up. 
Transthoracic echocardiography, performed 4 days and 2 months 
postoperatively, demonstrated severely reduced left ventricular 
function with no paravalvular regurgitation.
DisCussioN
Adult patients with CHD represent a challenging population due 
to increased technical complexity and high-risk comorbidities. 
Therefore, hybrid procedures are becoming increasingly popular 
in the treatment of a wide range of conditions in this cluster of 
patients.
 1. Transcatheter pulmonary valve implantation has emerged 
as an alternative to surgical pulmonary valve replacement. 
Currently, two devices are available for TPVI: the Melody 
valve (Medtronic, Minneapolis, MN, USA) and the Edwards 
Sapien XT valve (Edwards Lifesciences, Irvine, CA, USA) (4). 
The Melody valve has been validated for RVOTs up to 24 mm 
in diameter (5, 6), while the Edwards Sapien XT valve is avail-
able in 23, 26, and 29 mm sizes. The first patient presented 
in this paper had a dilated RVOT, with a diameter of 47 mm. 
Because of multiple comorbidities, it was decided not to 
replace the pulmonary valve with conventional surgery, which 
would have required CPB. However, the native RVOT was not 
suitable for a percutaneous TPVI due to an excessively dilated 
main pulmonary artery (47 mm). For this reason, plication 
of the main pulmonary artery was required. Furthermore, 
plication is not sufficient to create an appropriate landing 
zone for the Edwards Sapien XT valve; as a consequence, it is 
common practice to stent the native the RVOT before valve 
implantation (7). Therefore, we gained access for the main 
pulmonary artery plication via redo median sternotomy, 
which also allowed implantation of the RVOT stent and the 
Edwards Sapien XT prosthesis via a perventricular approach. 
At our institution, we have gained significant experience in 
hybrid pulmonary valve replacement, primarily in the context 
of pulmonary regurgitation after tetralogy of Fallot repair (8). 
In a retrospective study published in 2013, we compared the 
results of hybrid off-pump perventricular pulmonary valve 
implantation with conventional pulmonary valve replace-
ment: significant differences were found in favor of the hybrid 
approach with regards to operative time, postoperative 
hemoglobin level, postoperative bleeding, and need for blood 
products (9).
 2. Partial anomalous pulmonary venous drainage is an uncom-
mon congenital anomaly, with incidence reported to be 
between 0.4 and 0.7% in autopsy series. PAPVD with intact 
septum accounts for about 25–35% of all PAPVD cases (10, 
11). Furthermore, surgical treatment is safe, and both early 
and late events, including venous pathway stenosis, are rare 
(12). Hence, there is no widely agreed interventional manage-
ment for baffle obstruction. A conventional surgical approach 
to address this condition requires not only CPB but also aortic 
cross-clamp and cardioplegic arrest. Our second patient had 
undergone a PAPVD repair with transection and relocation 
technique; as a consequence, the stump of the superior vena 
5Rapetto et al. Hybrid Approaches to Complex ACHD
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cava had been converted into the inflow of the pulmonary 
veins into the left atrium at the time of the first operation. 
Approaching this anterior structure through a redo median 
sternotomy necessitated minimal dissection and provided 
direct access to the pericardial baffle for the interventional 
cardiologist.
 3. The incidence of paravalvular regurgitation after aortic 
and mitral valve replacement surgery is reported to be 
2–17% (13, 14). About 3% of all patients with paravalvular 
regurgitation require an interventional treatment because 
of heart failure, hemolysis, or both (14). Although reop-
erative surgery is currently the gold standard treatment 
for PVL, it carries high early and mid-term morbidity and 
mortality and significant risk of recurrence (15, 16). Various 
percutaneous and hybrid techniques have been developed 
over the last years to address paravalvular regurgitation 
avoiding redo sternotomy, CPB, and aortic cross-clamp (14, 
17). Randomized controlled trials comparing surgical and 
catheter closure of PVL are not currently available; however, 
early mortality in elective cases was reported to be 2.9% in 
a recent large series from UK and Irish centers (18). To our 
knowledge, there are no published series reporting results of 
transcatheter PVL closure in adults with previous diagnosis 
of atrioventricular septal defect. Although technical aspects 
of transapical PVL closure in such patients are probably the 
same that apply for patients who underwent mitral valve 
replacement for acquired valve disease, long-term results 
may be different due to different annular structure in the 
CHD group. In this paper, we presented a patient with 
both heart failure and hemolysis and severe PVL on a left 
atrioventricular valve mechanical prosthesis. We chose to 
close the PVL through a transcatheter transapical approach, 
in order to avoid a third redo sternotomy in a patient with 
significant left ventricular dysfunction. The procedure was 
uneventful, and the patient was discharged from the hospital 
with no obvious left atrioventricular valve regurgitation.
CoNCLuDiNg ReMaRKs
The choice of the optimal treatment strategy in adult patients 
with CHD often represents a challenge for cardiac surgeons and 
cardiologists. This is a heterogeneous population; hence, precise 
guidelines are seldom available to advise clinicians.
According to our experience, hybrid surgery is a promising 
therapeutic modality and it broadens the spectrum of therapeutic 
options for this group of patients characterized by a combination 
of complex anatomy and high preoperative risk. A multidiscipli-
nary and patient-tailored approach is crucial in these complex 
clinical scenarios.
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